IMMX

Immix Biopharma Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 5/10
Immix Biopharma sales and earnings growth
IMMX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -31.43%
  • FCF Y/Y↓ -144.61%
Immix Biopharma gross and profit margin trends
IMMX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ -2459.07%
Immix Biopharma net debt vs free cash flow
IMMX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Immix Biopharma stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks